In 2021, the name was changed to SMARCA4-deficient undifferentiated tumors (SMARCA4-UTs) according to the WHO classification of thoracic tumors, to incorporate the findings of more recent studies [7]. This evidence concerns the gene SMARCA4 and neoplasm of thorax.